• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于定量 PCR 终点评估的呼吸道合胞病毒中和测定法。

A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.

机构信息

Laboratory of DNA Viruses, Division of Viral Products, OVRR, CBER, FDA, Bethesda, MD 20892, USA.

出版信息

Virol J. 2013 Jun 15;10:195. doi: 10.1186/1743-422X-10-195.

DOI:10.1186/1743-422X-10-195
PMID:23767960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3686610/
Abstract

BACKGROUND

Few studies have used quantitative polymerase chain reaction (qPCR) as an approach to measure virus neutralization assay endpoints. Its lack of use may not be surprising considering that sample nucleic acid extraction and purification can be expensive, labor-intensive, and rate-limiting.

METHODS

Virus/antibody mixtures were incubated for one hour at 37°C and then transferred to Vero cell monolayers in a 96-well plate format. At 24 (or 48) hours post-infection, we used a commercially available reagent to prepare cell lysates amenable to direct analysis by one-step SYBR Green quantitative reverse transcription PCR using primers specific for the RSV-N gene, thereby obviating the need for cumbersome RNA extraction and purification. The neutralization titer was defined as the reciprocal of the highest dilution needed to inhibit the PCR signal by 90% when compared with the mean value observed in virus control wells in the absence of neutralizing antibodies.

RESULTS

We have developed a qPCR-based neutralization assay for human respiratory syncytial virus. Due to the sensitivity of qPCR in detecting virus replication, endpoints may be assessed as early as 24 hours post-infection. In addition, the dynamic range of qPCR provides a basis for the assay to be relatively robust to perturbations in input virus dose (i.e., the assay is in compliance with the Percentage Law).

CONCLUSIONS

This qPCR-based neutralization assay is suitable for automated high-throughput applications. In addition, our experimental approach may be generalizable for the rapid development of neutralization assays for other virus families.

摘要

背景

很少有研究使用定量聚合酶链反应(qPCR)来测量病毒中和测定终点。考虑到样本核酸提取和纯化可能既昂贵又费力,而且是速度的限制因素,因此它未被广泛应用可能并不奇怪。

方法

病毒/抗体混合物在 37°C 下孵育一小时,然后转移到 96 孔板格式的 Vero 细胞单层中。在感染后 24(或 48)小时,我们使用市售试剂制备细胞裂解物,这些裂解物适合通过一步 SYBR Green 定量逆转录 PCR 直接分析,从而避免了繁琐的 RNA 提取和纯化。中和滴度定义为与无中和抗体的病毒对照孔中观察到的平均值相比,抑制 PCR 信号降低 90%所需的最高稀释度的倒数。

结果

我们已经开发了一种基于 qPCR 的人类呼吸道合胞病毒中和测定法。由于 qPCR 在检测病毒复制方面的灵敏度,终点可以在感染后 24 小时内进行评估。此外,qPCR 的动态范围为该测定提供了相对稳健的基础,可抵抗输入病毒剂量的波动(即,该测定符合百分比定律)。

结论

这种基于 qPCR 的中和测定法适用于自动化高通量应用。此外,我们的实验方法可能适用于其他病毒家族的中和测定法的快速开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/bbf328aa59db/1743-422X-10-195-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/6e3f9fc7ce0f/1743-422X-10-195-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/242907304961/1743-422X-10-195-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/ffc916de9c6c/1743-422X-10-195-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/d63e86d6c5ed/1743-422X-10-195-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/a0272c466dd1/1743-422X-10-195-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/d2ff91c3a8c4/1743-422X-10-195-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/bbf328aa59db/1743-422X-10-195-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/6e3f9fc7ce0f/1743-422X-10-195-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/242907304961/1743-422X-10-195-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/ffc916de9c6c/1743-422X-10-195-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/d63e86d6c5ed/1743-422X-10-195-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/a0272c466dd1/1743-422X-10-195-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/d2ff91c3a8c4/1743-422X-10-195-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9a9/3686610/bbf328aa59db/1743-422X-10-195-7.jpg

相似文献

1
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.一种基于定量 PCR 终点评估的呼吸道合胞病毒中和测定法。
Virol J. 2013 Jun 15;10:195. doi: 10.1186/1743-422X-10-195.
2
RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.基于实时定量聚合酶链反应的人巨细胞病毒微中和试验,采用成纤维细胞和上皮细胞。
Vaccine. 2015 Dec 16;33(51):7254-7261. doi: 10.1016/j.vaccine.2015.10.110. Epub 2015 Nov 6.
3
Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.呼吸道合胞病毒引起的成人社区获得性肺炎中中和抗体的作用。
Clin Infect Dis. 2012 Apr;54(7):905-12. doi: 10.1093/cid/cir955. Epub 2012 Jan 11.
4
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.基于终点定量逆转录 PCR 的流感病毒中和检测方法的建立。
PLoS One. 2013;8(2):e56023. doi: 10.1371/journal.pone.0056023. Epub 2013 Feb 20.
5
A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.基于直接定量PCR的单纯疱疹病毒对抗病毒药物和中和抗体敏感性的测定。
J Virol Methods. 2017 Apr;242:46-52. doi: 10.1016/j.jviromet.2017.01.007. Epub 2017 Jan 16.
6
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay.基于高通量呼吸道合胞病毒荧光灶的微量中和试验的开发
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00225-17. Print 2017 Dec.
7
Evaluation of consistency in quantification of gene copy number by real-time reverse transcription quantitative polymerase chain reaction and virus titer by plaque-forming assay for human respiratory syncytial virus.通过实时逆转录定量聚合酶链反应评估人呼吸道合胞病毒基因拷贝数定量的一致性以及通过空斑形成试验评估病毒滴度的一致性。
Microbiol Immunol. 2018 Feb;62(2):90-98. doi: 10.1111/1348-0421.12563.
8
Development of a high-throughput assay to measure measles neutralizing antibodies.高通量检测麻疹中和抗体的方法的建立。
PLoS One. 2019 Aug 15;14(8):e0220780. doi: 10.1371/journal.pone.0220780. eCollection 2019.
9
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay.一种改进的高通量呼吸道合胞病毒(RSV)微量中和试验
J Vis Exp. 2019 Jan 26(143). doi: 10.3791/59025.
10
An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting.一种基于绿色荧光蛋白表达检测和自动噬斑计数的改良呼吸道合胞病毒中和测定法。
Virol J. 2012 Oct 31;9:253. doi: 10.1186/1743-422X-9-253.

引用本文的文献

1
Improved RSV Neutralization Assay Using Recombinant RSV Expressing Reporter Fluorescent Protein.使用表达报告荧光蛋白的重组呼吸道合胞病毒改进呼吸道合胞病毒中和试验。
Methods Protoc. 2025 Jun 4;8(3):60. doi: 10.3390/mps8030060.
2
Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.呼吸道合胞病毒感染患者鼻腔吸出物中呼吸道合胞病毒的稳定性
Influenza Other Respir Viruses. 2024 Dec;18(12):e70058. doi: 10.1111/irv.70058.
3
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication.

本文引用的文献

1
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.基于终点定量逆转录 PCR 的流感病毒中和检测方法的建立。
PLoS One. 2013;8(2):e56023. doi: 10.1371/journal.pone.0056023. Epub 2013 Feb 20.
2
Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.婴幼儿流感和呼吸道合胞病毒(RSV)疫苗:安全性、免疫原性和有效性。
Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13.
3
An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting.
XPO1 介导的核输出抑制剂可阻断呼吸道合胞病毒(RSV)的复制。
Sci Rep. 2021 Sep 28;11(1):19223. doi: 10.1038/s41598-021-98767-2.
4
Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection.在中东呼吸综合征冠状病毒感染动物模型中,靶向全长刺突蛋白的卵黄抗体的免疫治疗效果
Pharmaceuticals (Basel). 2021 May 26;14(6):511. doi: 10.3390/ph14060511.
5
Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.基于多重聚合酶链反应的中和试验(MPBN)用于三种抗脊髓灰质炎病毒中和抗体滴度的测定
Vaccines (Basel). 2020 Mar 5;8(1):120. doi: 10.3390/vaccines8010120.
6
Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.双价胡宁和马丘波实验疫苗,基于甲病毒 RNA 复制子载体。
Vaccine. 2020 Mar 23;38(14):2949-2959. doi: 10.1016/j.vaccine.2020.02.053. Epub 2020 Feb 25.
7
Development of a high-throughput assay to measure measles neutralizing antibodies.高通量检测麻疹中和抗体的方法的建立。
PLoS One. 2019 Aug 15;14(8):e0220780. doi: 10.1371/journal.pone.0220780. eCollection 2019.
8
Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein.用于检测抗人呼吸道合胞病毒G糖蛋白IgG抗体的荧光素酶免疫沉淀系统(LIPS)分析方法的开发。
Vaccines (Basel). 2019 Feb 1;7(1):16. doi: 10.3390/vaccines7010016.
9
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay.基于高通量呼吸道合胞病毒荧光灶的微量中和试验的开发
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00225-17. Print 2017 Dec.
10
Neutralization Assay for Zika and Dengue Viruses by Use of Real-Time-PCR-Based Endpoint Assessment.基于实时 PCR 终点评估的寨卡病毒和登革热病毒中和试验。
J Clin Microbiol. 2017 Oct;55(10):3104-3112. doi: 10.1128/JCM.00673-17. Epub 2017 Aug 9.
一种基于绿色荧光蛋白表达检测和自动噬斑计数的改良呼吸道合胞病毒中和测定法。
Virol J. 2012 Oct 31;9:253. doi: 10.1186/1743-422X-9-253.
4
Respiratory syncytial virus infection in adult populations.成人人群中的呼吸道合胞病毒感染
Infect Disord Drug Targets. 2012 Apr;12(2):98-102. doi: 10.2174/187152612800100116.
5
The burgeoning burden of respiratory syncytial virus among children.儿童呼吸道合胞病毒感染负担日益加重。
Infect Disord Drug Targets. 2012 Apr;12(2):92-7. doi: 10.2174/187152612800100099.
6
Respiratory syncytial virus vaccine development.呼吸道合胞病毒疫苗的研发。
Expert Rev Vaccines. 2011 Oct;10(10):1415-33. doi: 10.1586/erv.11.120.
7
Rapid detection of anti-Vaccinia virus neutralizing antibodies.快速检测抗牛痘病毒中和抗体。
Virol J. 2011 Mar 25;8:139. doi: 10.1186/1743-422X-8-139.
8
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.呼吸道合胞病毒疫苗研发的生物学挑战和技术机遇。
Immunol Rev. 2011 Jan;239(1):149-66. doi: 10.1111/j.1600-065X.2010.00972.x.
9
A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate.基于流式细胞术的 RSV 特异性中和抗体检测方法具有可重复性、高效性和准确性。
J Immunol Methods. 2010 Oct 31;362(1-2):180-4. doi: 10.1016/j.jim.2010.08.005. Epub 2010 Aug 19.
10
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.婴幼儿呼吸道病毒感染:病因、临床症状、病毒学和免疫学。
Clin Microbiol Rev. 2010 Jan;23(1):74-98. doi: 10.1128/CMR.00032-09.